FDA Inspection 1182041 — South Florida Institute For Reproductive Medicine, P.A.
The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on Oct 19, 2022 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- South Miami, FL (United States)